Ji-101

Other Medications

EU Experimental ES med_spain_not_available 1 Clinical Trials

Description

Ji-101 is an investigational medication currently being studied in clinical trials. It is being evaluated for its potential use in certain types of cancer, including advanced colorectal cancer specifically in patients whose tumors have a KRAS mutation. The trials are primarily focused on assessing the safety and determining the right dosage of Ji-101. It is being studied alone and in combination with other drugs like Everolimus. Ji-101 is not yet approved for treating colorectal cancer or any other condition.

Mechanism of Action

Ji-101 is being investigated for its effects on solid tumors. Clinical trials are exploring how it works and which specific pathways it might affect within cancer cells. The exact molecular target or mechanism of action is still being characterized during these early-phase studies.

Side Effects

Ji-101 is currently in early-phase clinical trials (Phase 1). Therefore The full range of potential side effects is still being evaluated. Safety is a primary focus of these trials. Participants in the trials are closely monitored for any adverse events. More information about side effects will become available as the trials progress.

Not all side effects are listed. Side effects vary by individual. Always consult your oncologist.

Clinical Trials

NCT01149434 med_phase_prefix1
Archived
Study of JI-101 in Patients With Advanced Low Grade Endocrine Tumors, Ovarian Cancers or K-RAS Mutant Colon Cancers
United States

Quick Info

CategoryOther Medications
EU Estado EMAExperimental
ES Acceso Españamed_spain_not_available
Clinical Trials1
View Clinical Trials Back to Drug Glossary

Related Medications

Uracil
Other Medications
767 trials
Leucovorin
Other Medications
625 trials
Trifluridine
Other Medications
44 trials
Paclitaxel
Other Medications
43 trials
Cyclophosphamid
Other Medications
40 trials
Cyclophosphamide
Other Medications
39 trials

Medical Disclaimer

This information is for educational purposes only and should not replace professional medical advice. Always consult your healthcare team before making treatment decisions.